Curevac

Receive News & Ratings for CureVac B.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CureVac B.V. and related companies with MarketBeat.

He went from helping to manufacture the vaccine for Curevac to colluding with total vaccine deniers.

Among these is CureVac, a company based in the German town of Tubingen, which has invented a new rapid-programming process for RNA that promises to be widely applicable.

An employee of German biopharmaceutical company CureVac working on a vaccine for the coronavirus.

Credit Suisse Group assumed coverage on shares of CureVac B.V. in a report on Tuesday.

Curevac is a private company founded in 2008 based in Tuebingen with other sites in Frankfurt and Boston.

CureVac is one of the noteworthy international biotech stocks developing coronavirus vaccines.

In a further potential complication, some EU negotiators have raised doubts about mRNA, which is also used in the potential COVID vaccines developed by Moderna and CureVac.

Moderna and CureVac were not immediately available to comment.